Pelayanan Informasi Obat dalam Layanan Telefarmasi pada Apotek X Kota Mataram
DOI:
https://doi.org/10.55606/klinik.v5i2.6335Keywords:
Digital Health Services, Drug Information Services, Pharmaceutical Care, Pharmacist, TelepharmacyAbstract
Telepharmacy is an innovation in remote pharmaceutical services that has become increasingly relevant along with the rapid development of information and communication technology in the healthcare sector. This service enables pharmacists to continue providing optimal pharmaceutical care without direct face-to-face interaction. This study aimed to describe the implementation of drug information services provided by pharmacists through telepharmacy at Pharmacy X in Mataram City and to evaluate their compliance with pharmaceutical service standards as regulated in the Regulation of the Minister of Health of the Republic of Indonesia Number 73 of 2016. This study employed a descriptive design with a cross-sectional approach, involving 40 patient interactions conducted via WhatsApp over a one-month period. The collected data included the types of medicines purchased by patients and the forms of drug information provided by pharmacists. The medicines were classified according to therapeutic categories, while drug information was analyzed using indicators based on pharmaceutical service regulations. The results showed that the most frequently purchased medicines were respiratory system drugs (26.67%), analgesic/antipyretic drugs (22.22%), and medicines for dyspepsia (17.78%). The most commonly provided drug information included dosage instructions (71.74%), explanations of special dosage forms (87.5%), and duration of use (54.35%). However, information regarding side effects (13.04%) and drug interactions (10.87%) was still limited. All patients receiving antibiotics were educated to complete their medication as prescribed (100%). Overall, drug information services delivered through telepharmacy at Pharmacy X were in accordance with pharmaceutical service standards, although improvements in clinical education are still needed to strengthen the quality and safety of digital pharmacy services.
References
Alexander, E., Butler, C. D., Darr, A., Jenkins, M. T., Long, R. D., Shipman, C. J., & Traynor, K. (2021). ASHP statement on telepharmacy. American Journal of Health-System Pharmacy, 78(9), 755–759.
Almazrou, S., Alaujan, S., Al-Aqeel, S., & Alhossan, A. (2022). Patients’ perceptions and satisfaction with telepharmacy services during the COVID-19 pandemic. Journal of Pharmaceutical Policy and Practice, 15(1), 1–9.
Ameri, A., Salmanizadeh, F., Keshvardoost, S., & Bahaadinbeigy, K. (2020). Investigating pharmacists’ views on telepharmacy: Prioritizing key relationships, barriers, and benefits. Journal of Pharmacy Technology, 36(5), 171–178.
Ameri, A., Salmanizadeh, S., & Bahaadinbeigy, K. (2020). Telepharmacy and patient counseling in the Middle East: Opportunities and challenges. International Journal of Pharmacy Practice, 28(6), 638–644.
Aryanto, F., Khairunnisa, A., Rhea, B., Ilmi, M., Milenia, N., Salfa, R., Auli, R., Shavira, S., Afrilians, S., Ayatulloh, S., Hayfa, S., Nasikatus, S., Putri, S., & Rindang, M. (2023). Penerapan layanan telefarmasi oleh apoteker di apotek wilayah Surabaya pada masa pandemi COVID-19. Jurnal Farmasi Komunitas, 10(1), 54–62.
Bukhari, N., Rasheed, H., Nayyer, B., & Babar, Z. U. D. (2021). Pharmacy at a crossroads: Telepharmacy and the COVID-19 pandemic. Research in Social and Administrative Pharmacy, 17(1), 1998–2002.
Dini, A. R., Safitri, Y., & Lestari, H. (2023). Perilaku konsumsi suplemen kesehatan di kalangan masyarakat pasca pandemi. Jurnal Kesehatan Masyarakat, 15(2), 104–111.
Elnaem, M. H., Akkawi, M. E., Al-Shami, A. M., & Cheema, E. (2023). Telepharmacy services and pharmaceutical care: A systematic review of outcomes and challenges. Exploratory Research in Clinical and Social Pharmacy, 9, 100230.
Fitriana, A., Putri, R. M., & Dewi, Y. L. (2023). Persepsi pasien terhadap kebutuhan edukasi penggunaan obat pada layanan farmasi daring. Jurnal Farmasi Indonesia, 14(1), 45–53.
Frenk, J., & Chen, L. (2022). Health professionals for a new century: Transforming education to strengthen health systems in an interdependent world. The Lancet, 376(9756), 1923–1958.
Handayani, R. S., Dewi, N. L. K., & Aslamiah, L. (2021). Utilization pattern of telepharmacy services in community pharmacy: A descriptive study. Indonesian Journal of Pharmaceutical Policy and Management, 6(2), 75–82.
Kassam, R., Collins, J. B., & Berkowitz, J. (2012). Patient-centered care in pharmacy: Model development and evaluation. Canadian Pharmacists Journal, 145(6), 289–297.
Kassam, R., Farris, K. B., & Fernandez, N. (2012). Impact of pharmacist-provided information on medication adherence. Canadian Pharmacists Journal, 145(1), 28–35.
Kementerian Kesehatan Republik Indonesia. (2016). Peraturan Menteri Kesehatan Republik Indonesia Nomor 73 Tahun 2016 tentang standar pelayanan kefarmasian di apotek. Kementerian Kesehatan Republik Indonesia.
Nababan, J. S., Pambudi, R., & Sari, N. M. (2023). Implementation of telepharmacy services in community pharmacies in Indonesia. Indonesian Journal of Pharmacy and Health Sciences, 12(2), 101–110.
Poudel, A., & Nissen, L. M. (2016). Telepharmacy: A pharmacist’s perspective on the clinical benefits and challenges. Integrated Pharmacy Research & Practice, 5, 75–82.
Riskiyah, R., & Nurrahmah, S. (2020). Dampak perubahan musim terhadap kejadian penyakit di Indonesia: Tinjauan literatur. Jurnal Kesehatan Lingkungan, 10(2), 84–90.
Wahyuni, A., & Ramadhani, D. (2022). Evaluasi penggunaan obat topikal dan inhalasi pada pasien di pelayanan telefarmasi. Jurnal Ilmu Farmasi dan Klinik, 10(1), 59–66.
World Health Organization. (1994). The role of the pharmacist in the health care system: Preparing the future pharmacist. World Health Organization.
World Health Organization. (2021). AWaRe classification database of antibiotics. World Health Organization.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Jurnal Ilmiah Kedokteran dan Kesehatan
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
